Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma

Overview of attention for article published in Cancer Imaging, February 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 15 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 17,383 followers.

RT @ICIS_News: PET imaging detects a higher rate of complete responses compared to CT in patients with #melanoma ending #immunotherapy and…

16 Feb 2022

Reply Repost Favourite

New article: Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma https://t.co/KZ5chgdlQ1 #melanoma #oncology https://t.co/XOo9aXos4t

07 Feb 2022

Reply Repost Favourite

Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma https://t.co/igAcgwyQfW

07 Feb 2022

Reply Repost Favourite

RT @ICIS_News: PET imaging detects a higher rate of complete responses compared to CT in patients with #melanoma ending #immunotherapy and…

06 Feb 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.